News
03/11/10, General Medicine FDA Grants Orphan Drug Status to Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Berlin, March 11, 2010 – Bayer Schering Pharma AG, Germany, announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for the ciprofloxacin... External Link: more
IMI-Logo
IMI – Innovative Medicines Initiative
EMTRAIN: European platform for new educational and training programs in pharmaceutical medicine.
more